100%
Questions marked with an
*
are required
Exit Survey
59th ASH Annual Meeting Evaluation of the Continuing Conversation with the Speakers on "
Advances in Cellular Immunotherapy for Lymphoid Malignancies"
*
Q1: Did you attend the Scientific Program session associated with this Continuing Conversation with the Speakers session?
Yes
No
Not Sure
Comments/Suggestions:
*
Q2: Have you attended a Continuing Conversation with the Speakers session in the past?
Yes
No
Not Sure
Comments/Suggestions:
*
Q3: Was there a hard copy of conflict of interest (COI) disclosure form present for each speaker and the chair?
Yes
No
Not Sure
Comments/Suggestions:
*
Q4: Did all three speakers and session chair attend the session?
Yes
No
Not Sure
Comments/Suggestions:
*
Q5: Did the session’s format foster informal interaction and interesting discussion?
Yes
No
Not Sure
Comments/Suggestions:
*
Q6: Did you establish new collaborations/relationships at this session?
Yes
No
Not Sure
Comments/Suggestions:
*
Q7: What is unique about this session compared to other sessions at ASH that makes it valuable for attendees?
*
Q8: How did you find out about this session, and what made you interested in attending?
*
Q9: Should ASH continue to offer such sessions in the future?
Yes
No
Not Sure
Comments/Suggestions:
*
Q10: Is there anything ASH could change to improve this session?
*
Q12: What are your research interests? (please check all that apply):
Epigenetics and Genomics
Blood Disorders in Childhood
Bone Marrow Failure
Genome Editing and Gene Therapy
Genomic Profiling and Chemical Biology
Hematopathology and Clinical Laboratory Hematology
Hematopoiesis
Hemostasis
Immunology and Host Defense
Immunotherapies
Iron and Heme
Lymphoid Neoplasia
Megakaryocytes and Platelets
Myeloid Biology
Myeloid Neoplasia
Plasma Cell Neoplasia
Precision Medicine
Red Cell Biology
Stem Cells and Regenerative Medicine
Thrombosis & Vascular Biology
Transfusion Medicine
Transplantation Biology and Cellular Therapies
Other
Q13: Please provide your name and email address.
Name
:
Affiliation
:
Email Address
:
Loading...
close
Loading...
Close
qprun1.questionpro.net